"bharath-biotech"

A single dosage of the vaccine induces antibodies to protect against disease among 99 percent of participants.

This assertion came from Bharath Biotech, after Brazil indicated suspension of its contract with the Hyderabad-based vaccine maker after allegations of irregularities in the deal surfaced.

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

Announcing the price cut on Thursday, the company maintained that it was deeply concerned with the critical pandemic situation in India